Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 9, 2010, Pages 2268-2272

  Bak, Istvan ^a   Czompa, Attila ^a   Juhasz, Bela ^a   Lekli, Istvan ^a   Tosaki, Arpad ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

HO 1 knockout; HO 1 transgenic; Ischemia reperfusion; Isolated mouse hearts

Indexed keywords

MUS; MUS MUSCULUS; RATTUS;

HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL; CARDIAC MUSCLE; COMPLICATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY; RAT; TRANSGENIC MOUSE; VENTRICULAR FIBRILLATION;

ANIMALS; GENE EXPRESSION; HEME OXYGENASE-1; MALE; MEMBRANE PROTEINS; MICE, TRANSGENIC; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; VENTRICULAR FIBRILLATION;

EID: 78649337863     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01142.x     Document Type: Article

References (12)

1. Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008; 52: 971-8.
2. Bach FH. Heme oxygenase-1 as a protective gene. Wien Klin Wochenschr. 2002; 114: 1-3.
3. Kirkby KA, Adin CA. Products of heme oxygenase and their potential therapeutic applications. Am J Physiol Renal Physiol. 2006; 290: F563-71.
4. Bak I, Papp G, Turoczi T, et al. The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med. 2002; 33: 639-48.
5. Bak I, Szendrei L, Turoczi T, et al. Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J. 2003; 17: 2133-5.
6. Varadi J, Lekli I, Juhasz B, et al. Beneficial effects of carbon monoxidereleasing molecules on post-ischemic myocardial recovery. Life Sci. 2007; 80: 1619-26.
7. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004; 119: 19-31.
8. Splawski I, Timothy KW, Decher N, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA. 2005; 102: 8089-96.
9. Araujo JA, Meng L, Tward AD, et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol. 2003; 171: 1572-80.
10. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007; 59: 418-58.
11. Piantadosi CA, Carraway MS, Babiker A, et al. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res. 2008; 103: 1232-40.
12. Szendrei L, Turoczi T, Kovacs P, et al. Mitochondrial gene expression and ventricular fibrillation in ischemic/reperfused nondiabetic and diabetic myocardium. Biochem Pharmacol. 2002; 63: 543-52.